4
Changes in Ownership
Jade Biosciences, Inc. Filed Acc 0001415889-22-012273
Dake Benjamin T sold 40,000 shares at an average $17.67 ($706,772)
- Dake Benjamin T acquired 40,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-06 | Exercise or conversion : show line 1 in the form | +2,412 | $1.74 | $4,197 | 2,412 | D |
| 2022-12-06 | Exercise or conversion : show line 2 in the form | +37,588 | $2.14 | $80,438 | 40,000 | D |
| 2022-12-06 | Sale : show line 3 in the form | −2,011 | $15.61 | $31,386 | 37,989 | D |
| 2022-12-06 | Sale : show line 4 in the form | −1,259 | $16.90 | $21,275 | 36,730 | D |
| 2022-12-06 | Sale : show line 5 in the form | −36,115 | $17.80 | $642,861 | 615 | D |
| 2022-12-06 | Sale : show line 6 in the form | −615 | $18.29 | $11,250 | 0 | D |
| Open-market sales · 40,000 sh · avg $17.67 · $706,772 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2022-12-06 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −905 | $1.74 | 2030-09-03 | 906 | 11,772 | D |
| 2022-12-06 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −1,507 | $1.74 | 2030-09-03 | 1,507 | 30,136 | D |
| 2022-12-06 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −1,018 | $2.14 | 2031-04-01 | 1,018 | 28,515 | D |
| 2022-12-06 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −36,570 | $2.14 | 2031-04-01 | 36,570 | 218,030 | D |
Loading xslF345X03/form4-12082022_061206.xml…